Dr. Bradley R. Grimsley, MD
Vascular Surgery (Vascular Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Emory University School of Medicine (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 429
Licensed in Texas since 1999, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: Emory University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
TX license K8184 (first issued 1999; active) -
Specialist
TX license K8184 (first issued 1999; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor University Medical Center Dallas, TX
- Baylor Scott & White Medical Center- Waxahachie Waxahachie, TX
- Baylor Scott & White Heart & Vascular Hospital - Dallas Dallas, TX
Medical groups
- Healthtexas Provider Network (2,697 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 429
- Services billed
- 1,112
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 204 | 172 |
| Ultrasound of both sides of head and neck blood flow | 105 | 98 |
| New patient office or other outpatient visit, 45-59 minutes | 90 | 90 |
| Ultrasound study of arm and leg arteries | 55 | 49 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 51 | 47 |
| Ultrasonic guidance for blood vessel access | 46 | 42 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 44 | 35 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 39 | 39 |
| Insertion of stent and blood clot protection device in neck artery with review by radiologist | 33 | 30 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 32 | 31 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Dallas, TX | 217 |
| Eliquis (apixaban) Other prescribers in Dallas, TX | 92 |
| Gabapentin Other prescribers in Dallas, TX | 29 |
| Xarelto (rivaroxaban) Other prescribers in Dallas, TX | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 23 companies reported 62 payments worth $1,996 in total to this clinician.
| Neuros Medical, Inc. | $411 |
|---|---|
| Axogen | $408 |
| Imperative Care, Inc | $246 |
| Medtronic, Inc. | $188 |
| Penumbra, Inc. | $159 |
| Stryker Corporation | $120 |
| W. L. Gore & Associates, Inc. | $98.45 |
| Bolton Medical Inc | $40.52 |
| Food and Beverage | $1,995 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $5,200 in research payments for these studies, mostly to the institutions running them.
- Roadster 3
Boston Scientific Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.